Search research articles
Contact Us
Filters
Showing results (91-100 of 138) with videos related to
Page
of 14
Sort By:
International Journal of Antimicrobial Agents
|
October 19, 2019
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward
Armand Van Deun, Tom Decroo, Sabira Tahseen, et al.
Plos One
|
January 29, 2024
Correction: Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India
Chinmay Laxmeshwar, Mrinalini Das, Taanya Mathur, et al.
Plos One
|
February 11, 2022
Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India
Chinmay Laxmeshwar, Mrinalini Das, Taanya Mathur, et al.
Plos One
|
December 22, 2023
Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation
Tinne Gils, Mashaete Kamele, Thandanani Madonsela, et al.
Plos One
|
October 19, 2020
Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe
Richard Makurumidze, Jozefien Buyze, Tom Decroo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 7, 2023
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin
Mahamadou Bassirou Souleymane, Sani Kadri, Alberto Piubello, et al.
Trials
|
December 13, 2022
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation
Mahamadou Bassirou Souleymane, Tom Decroo, Alphazazi Soumana, et al.
Plos One
|
January 8, 2020
Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015
Richard Makurumidze, Tsitsi Mutasa-Apollo, Tom Decroo, et al.
AIDS Research and Therapy
|
July 9, 2022
Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
Trudy Tholakele Mhlanga, Bart K M Jacobs, Tom Decroo, et al.
Plos One
|
May 19, 2020
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance
Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 138) with videos related to
Sort By:
Page
of 14
International Journal of Antimicrobial Agents
|
October 19, 2019
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward
Armand Van Deun, Tom Decroo, Sabira Tahseen, et al.
Plos One
|
January 29, 2024
Correction: Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India
Chinmay Laxmeshwar, Mrinalini Das, Taanya Mathur, et al.
Plos One
|
February 11, 2022
Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India
Chinmay Laxmeshwar, Mrinalini Das, Taanya Mathur, et al.
Plos One
|
December 22, 2023
Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation
Tinne Gils, Mashaete Kamele, Thandanani Madonsela, et al.
Plos One
|
October 19, 2020
Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe
Richard Makurumidze, Jozefien Buyze, Tom Decroo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 7, 2023
High rate of adverse drug reactions with a novel tuberculosis re-treatment regimen combining triple doses of both isoniazid and rifampicin
Mahamadou Bassirou Souleymane, Sani Kadri, Alberto Piubello, et al.
Trials
|
December 13, 2022
Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation
Mahamadou Bassirou Souleymane, Tom Decroo, Alphazazi Soumana, et al.
Plos One
|
January 8, 2020
Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015
Richard Makurumidze, Tsitsi Mutasa-Apollo, Tom Decroo, et al.
AIDS Research and Therapy
|
July 9, 2022
Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
Trudy Tholakele Mhlanga, Bart K M Jacobs, Tom Decroo, et al.
Plos One
|
May 19, 2020
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance
Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, et al.
Page
of 14